5 Einträge gefunden

1. Bevacizumab versus alkylating chemotherapy in recurrent glioblastoma

   1. Seystahl, Katharina
   2. Hentschel, Bettina
   3. Loew, Sarah
   4. Gramatzki, Dorothee
   5. Felsberg, Jörg
   6. Herrlinger, Ulrich
   7. Westphal, Manfred

   2020 - Forschungsinformationssystem des UKE
2. Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations

   1. Hartmann, Christian
   2. Hentschel, Bettina
   3. Simon, Matthias
   4. Westphal, Manfred
   5. Schackert, Gabriele
   6. Tonn, Jörg C
   7. Loeffler, Markus

   2013 - Forschungsinformationssystem des UKE
3. Predictive impact of MGMT promoter methylation in glioblastoma of the elderly.

   1. Reifenberger, Guido
   2. Hentschel, Bettina
   3. Felsberg, Jörg
   4. Schackert, Gabriele
   5. Simon, Matthias
   6. Schnell, Oliver
   7. Westphal, Manfred

   2012 - Forschungsinformationssystem des UKE
4. Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.

   1. Felsberg, Jörg
   2. Thon, Niklas
   3. Eigenbrod, Sabina
   4. Hentschel, Bettina
   5. Sabel, Michael C
   6. Westphal, Manfred
   7. Schackert, Gabriele

   2011 - Forschungsinformationssystem des UKE
5. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.

   1. Hartmann, Christian
   2. Hentschel, Bettina
   3. Wick, Wolfgang
   4. Capper, David
   5. Felsberg, Jörg
   6. Simon, Matthias
   7. Westphal, Manfred

   2010 - Forschungsinformationssystem des UKE